Frontier Capital Management’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Frontier Capital Management’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-100,878	Closed	-$5.44M	–	339
2017 Q4	$5.44M	Sell	100,878 -856,776	-89%	-$46.9M	0.04%	258
2017 Q3	$54.7M	Sell	957,654 -86,047	-8%	-$5.04M	0.39%	103
2017 Q2	$62.8M	Buy	+1,043,701	New	+$59.4M	0.46%	87

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Frontier Capital Management's BIVV Position: Q1 2018 in Review

Frontier Capital Management sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 100,878 shares — an estimated $5.44M sold.

Frontier Capital Management first reported a position in BIVV in Q2 2017 and held it in 3 quarters. The position peaked at $62.8M in Q2 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

Frontier Capital Management reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Frontier Capital Management sold 100,878 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $5.44M.
Frontier Capital Management first reported a position in Bioverativ Inc. Common Stock in Q2 2017 and held it in 3 quarters.
Frontier Capital Management's Bioverativ Inc. Common Stock position peaked at $62.8M in Q2 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Frontier Capital Management's 13F filing for Q1 2018, filed 30 Apr 2018.